Canada Opens its Doors to Global Med Technologies(R), Inc.
April 05 2005 - 1:14PM
PR Newswire (US)
Canada Opens its Doors to Global Med Technologies(R), Inc. First
Canadian Site has Implemented SafeTrace Tx(R) DENVER, April 5
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a
division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN
BOARD: GLOB) ("Global Med" or the "Company"), announced the first
Canadian customer to go live on its SafeTrace Tx*(R) advanced
transfusion management system. Canada is one of several
international markets targeted for growth by Wyndgate. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Will
Willman, Senior Vice President of International Business
Development stated, "The Global Med and Canadian team worked well
together in the implementation of this Canadian site and proved
that our blood bank solutions are architected to operate
efficiently in the international marketplace. This first Canadian
customer will provide an excellent reference site and has the
potential to accelerate our expansion into Canada." Mr. Willman
added, "Under extreme pressure because its old blood bank system
was being removed from the market, this client was extremely
pleased that Wyndgate was able to meet its aggressive
implementation timelines." Thomas F. Marcinek, President and COO of
Global Med, stated, "The high quality of our products and the
competency and dedication of our people provide the foundation for
future installations in Canada and other international markets.
These markets provide a previously untapped potential for Global
Med, and we are excited about the prospect of expanding our
international business." About Global Med Technologies, Inc. Global
Med Technologies, Inc. is an international e-Health, medical
information technology company, providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies division is a leading supplier of information
management systems to U.S. and international blood centers and
hospital transfusion centers. Current clients of Wyndgate's
products and services manage more than 3 million units of blood, or
over 22% of the U.S. blood supply, each year. Wyndgate's products
are also being implemented in sub-Saharan Africa. Together, the
SafeTrace Tx advanced transfusion management system and the
SafeTrace(R) donor management system provide Vein-to-Vein(R)
tracking from donor collection to patient transfusion. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe", "estimate",
"project", "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R),
Inc., +1-303-238-2000; or Investor Relations, John Nesbett, or
Jordan Silverstein, both of The Investor Relations Group,
+1-212-825-3210, both for Global Med Technologies Web site:
http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web
site: http://www.globalmedtech.com/
Copyright